Immunocryosurgery is a safe and feasible treatment for basal cell carcinoma and Bowen disease in renal transplant recipients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immunocryosurgery is a safe and feasible treatment for basal cell carcinoma and Bowen disease in renal transplant recipients

Published:2022-03-20 Issue:5 Volume:35 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Tsironi Theodora¹,Gaitanis Georgios¹^ORCID,Pappas Charalambos²,Koutlas Vasileios²,Dounousi Evangelia²³,Bassukas Ioannis D.¹

Affiliation:

1. Department of Skin and Venereal Diseases, Faculty of Medicine, School of Health Sciences University of Ioannina, University Campus Ioannina Greece

2. Department of Nephrology University Hospital of Ioannina Ioannina Greece

3. Department of Nephrology, Faculty of Medicine School of Health Sciences, University of Ioannina, University Campus Ioannina Greece

Publisher

Hindawi Limited

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.15405

Reference16 articles.

1. Skin cancer in solid organ transplant recipients: Advances in therapy and management

2. Skin Cancers after Organ Transplantation

3. Swiss clinical practice guidelines for skin cancer in organ transplant recipients;Hofbauer GF;Swiss Med Wkly,2009

4. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens

5. Immunocryosurgery for Non-superficial Basal Cell Carcinoma: A Prospective, Open-label Phase III Study for Tumours ≤ 2 cm in Diameter

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Carcinoma escamoso cutáneo en pacientes trasplantados de órgano sólido: revisión de la literatura;Medicina Clínica;2024-07

2. Basal Cell Carcinoma—A Retrospective Descriptive Study Integrated in Current Literature;Life;2023-03-19

3. The Feasibility of Immunocryosurgery in the Treatment of Non-Superficial, Facial Basal Cell Carcinoma That Relapsed after Standard Surgical Excision: An Experience Report from Two Centers;Current Oncology;2022-11-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3